Increased chromosome 20 copy number detected by fluorescence in situ hybridization (FISH) in malignant melanoma. 1997

J H Barks, and F H Thompson, and R Taetle, and J M Yang, and J F Stone, and J A Wymer, and R Khavari, and X Y Guan, and J M Trent, and D Pinkel, and M A Nelson
Graduate Interdisciplinary Program in Genetics, University of Arizona, Tucson, USA.

DNA amplification is an important mechanism of tumor progression that allows cancer cells to up-regulate the expression of critical genes such as oncogenes and genes conferring drug resistance. Recent studies using comparative genomic hybridization (CGH) revealed increased DNA copies of 20q sequences in 7 melanoma cell lines and B archival metastatic melanoma lesions. To evaluate chromosome 20 abnormalities in more detail and to resolve discrepancies between karyotype and CGH findings, we performed FISH analysis of metaphase cells in 13 melanoma cell lines (including the 7 lines used for CGH) and 9 primary melanoma specimens by using a whole chromosome paint specific for chromosome 20. All 13 cell lines (100%) and 8/9 primary tumors (89%) showed extra copies of chromosome 20 relative to tumor ploidy. Additionally, 6/14 cell lines (43%) and 2/8 primary tumors (25%) showed translocated chromosome 20 material previously undetected by standard cytogenetics. Cytologic evidence for gene amplification was also found in one cell line, which contained an add(20)(p13), with additional DNA being derived from 20q sequences. These data suggest that overrepresentation of a gene or genes important for melanoma pathogenesis resides on the long arm of chromosome 20.

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008677 Metaphase The phase of cell nucleus division following PROMETAPHASE, in which the CHROMOSOMES line up across the equatorial plane of the SPINDLE APPARATUS prior to separation.
D011003 Ploidies The degree of replication of the chromosome set in the karyotype. Ploidy
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D002872 Chromosome Deletion Actual loss of portion of a chromosome. Monosomy, Partial,Partial Monosomy,Deletion, Chromosome,Deletions, Chromosome,Monosomies, Partial,Partial Monosomies
D002890 Chromosomes, Human, Pair 20 A specific pair of GROUP F CHROMOSOMES of the human chromosome classification. Chromosome 20
D005784 Gene Amplification A selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Laboratory techniques have been introduced for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells, or generation of extrachromosomal sequences from rolling circle replication. Amplification, Gene
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J H Barks, and F H Thompson, and R Taetle, and J M Yang, and J F Stone, and J A Wymer, and R Khavari, and X Y Guan, and J M Trent, and D Pinkel, and M A Nelson
February 2003, Cytopathology : official journal of the British Society for Clinical Cytology,
J H Barks, and F H Thompson, and R Taetle, and J M Yang, and J F Stone, and J A Wymer, and R Khavari, and X Y Guan, and J M Trent, and D Pinkel, and M A Nelson
October 1997, Cancer genetics and cytogenetics,
J H Barks, and F H Thompson, and R Taetle, and J M Yang, and J F Stone, and J A Wymer, and R Khavari, and X Y Guan, and J M Trent, and D Pinkel, and M A Nelson
January 2005, Endocrine pathology,
J H Barks, and F H Thompson, and R Taetle, and J M Yang, and J F Stone, and J A Wymer, and R Khavari, and X Y Guan, and J M Trent, and D Pinkel, and M A Nelson
November 1997, Cancer genetics and cytogenetics,
J H Barks, and F H Thompson, and R Taetle, and J M Yang, and J F Stone, and J A Wymer, and R Khavari, and X Y Guan, and J M Trent, and D Pinkel, and M A Nelson
January 2002, Journal of neuro-oncology,
J H Barks, and F H Thompson, and R Taetle, and J M Yang, and J F Stone, and J A Wymer, and R Khavari, and X Y Guan, and J M Trent, and D Pinkel, and M A Nelson
May 1995, The American journal of pathology,
J H Barks, and F H Thompson, and R Taetle, and J M Yang, and J F Stone, and J A Wymer, and R Khavari, and X Y Guan, and J M Trent, and D Pinkel, and M A Nelson
April 2008, Cancer genetics and cytogenetics,
J H Barks, and F H Thompson, and R Taetle, and J M Yang, and J F Stone, and J A Wymer, and R Khavari, and X Y Guan, and J M Trent, and D Pinkel, and M A Nelson
January 2015, Journal of the Association of Genetic Technologists,
J H Barks, and F H Thompson, and R Taetle, and J M Yang, and J F Stone, and J A Wymer, and R Khavari, and X Y Guan, and J M Trent, and D Pinkel, and M A Nelson
December 1996, Cancer genetics and cytogenetics,
J H Barks, and F H Thompson, and R Taetle, and J M Yang, and J F Stone, and J A Wymer, and R Khavari, and X Y Guan, and J M Trent, and D Pinkel, and M A Nelson
September 2007, Mutagenesis,
Copied contents to your clipboard!